Coherus BioSciences Inc
Change company Symbol lookup
Select an option...
CHRS Coherus BioSciences Inc
CNCE Concert Pharmaceuticals Inc
BL Blackline Inc
DFEN Direxion Daily Aerospace & Defense Bull 3X Shares Direxion Daily Aerospace
NVRO Nevro Corp
DBI Designer Brands Inc
UONE Urban One Inc
SONY Sony Group Corp
PBF PBF Energy Inc
TRP TC Energy Corp
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Coherus BioSciences, Inc. is a commercial stage biotherapeutics company. The Company is focused on the biosimilar and immuno-oncology market primarily in the United States. The Company’s pipeline includes the four categories product candidates, Oncology pipeline, Immunology pipeline, Ophthalmology pipeline and Small Molecule pipeline. Oncology pipeline includes Toripalimab, an anti-PD-1 antibody; UDENYCA (pegfilgrastim-cbqv); CHS-305, a bevacizumab (Avastin) biosimilar. Immunology pipeline includes CHS-1420, an anti-TNF product candidate, as an adalimumab (Humira) biosimilar. Ophthalmology pipeline includes CHS-201, a ranibizumab (Lucentis) biosimilar. CHS-201, a ranibizumab (Lucentis) biosimilar. Small Molecule pipeline includes CHS-131, an oral, small-molecule drug candidate. CHS-131 is a once-daily oral drug candidate for non-alcoholic steatohepatitis (NASH) and other metabolic conditions.

Closing Price
$12.29
Day's Change
-0.45 (-3.53%)
Bid
--
Ask
--
B/A Size
--
Day's High
12.72
Day's Low
12.01
Volume
(Light)
Volume:
736,295

10-day average volume:
1,023,351
736,295
  • Prev Close
    12.74
  • Today's Open
    12.72
  • Day's Range
    12.01-12.72
  • Avg Vol (10-day)
    1.0M
  • Last (time)
    4:00p ET 01/25/22
  • Last (size)
    1
  • 52-Wk Range
    11.94 - 22.22
    LowHigh
  • (01/27/21 - 01/24/22)
    2.97%
  • 43.0%
  • Market Cap
    943.7M
  • Shares Outstanding
    76.8M
  • -3.13
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.0
  • 100.37
  • (% of float 12/31/21)
    10.56

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.